about
Colorectal endoscopic submucosal dissection: Recent technical advances for safe and successful proceduresEndoscopic submucosal dissection in early gastric cancer in elderly patients and comorbid conditionsSolitary fibrous tumor of the liver from development to resection[Concomitant use of romiplostim and chemotherapy for advanced rectal cancer associated with idiopathic thrombocytopenic purpura].Endoscopic surveillance strategy after endoscopic resection for early gastric cancer.Risk of perforation in balloon dilation associated with steroid injection for preventing esophageal stricture after endoscopic submucosal dissectionLymph node enlargement after definitive chemoradiotherapy for clinical stage I esophageal squamous cell carcinomaRenal dysfunction is an independent risk factor for bleeding after gastric ESDHelicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanismsFrequency of coexistent carcinoma in sessile serrated adenoma/polyps and traditional serrated adenomas removed by endoscopic resection.Gastric Contraction Imaging System Using a 3-D Endoscope.Gastric ESD under Heparin Replacement at High-Risk Patients of Thromboembolism Is Technically Feasible but Has a High Risk of Delayed Bleeding: Osaka University ESD Study Group.Clinical problems with antithrombotic therapy for endoscopic submucosal dissection for gastric neoplasms.Combination of two-hour post-endoscopic retrograde cholangiopancreatography amylase levels and cannulation times is useful for predicting post-endoscopic retrograde cholangiopancreatography pancreatitis.Current state of practice for colonic diverticular bleeding in 37 hospitals in Japan: A multicenter questionnaire study.Comparative study of esomeprazole and lansoprazole in triple therapy for eradication of Helicobacter pylori in Japan.Adverse events of stapling in thoracic surgery: relations between an incidence of adverse events and a stapling volume.Esophageal adenocarcinoma with white opaque substance observed by magnifying endoscopy with narrow band imaging.Clinical use of molecular targeted agents for primary small bowel adenocarcinoma: A multicenter retrospective cohort study by the Osaka Gut Forum.The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.[18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) was useful tool for detecting tuberculous peritonitis: report of a case].Juvenile hepatocellular carcinoma with congestive liver cirrhosis.Pancreatic intraductal tubulopapillary neoplasm with associated invasive cancer successfully treated by total pancreatectomy: A case report.Clinical outcomes of endoscopic submucosal dissection for superficial esophageal neoplasms: a multicenter retrospective cohort study.[Effectiveness of anti-tumor necrosis factor-α therapy in Crohn's disease with abscesses around the sigmoid colon: a case report].Colon adenocarcinoma with dome-like phenotype: characteristic endoscopic ultrasonography (EUS) findings.Histological complete response in a patient with advanced biliary tract cancer treated by gemcitabine/cisplatin/S-1 combination chemotherapy: A case reportEsophageal carcinoma originating in the surface epithelium with immunohistochemically proven esophageal gland duct differentiation: A case report.Post-transplant lymphoproliferative disorder of the ileum diagnosed by double-balloon enteroscopy.Esophageal early basaloid squamous carcinoma with unusual narrowband imaging magnified endoscopy findings.Phase I trial of gemcitabine dose escalation with concurrent radiotherapy for patients with locally advanced pancreatic cancer.Gastroesophageal reflux disease related to diabetes: Analysis of 241 cases with type 2 diabetes mellitus.Mucosa-associated lymphoid tissue (MALT) lymphoma of the esophagus.Clinical features of post-polypectomy bleeding associated with heparin bridge therapy.Upregulation of GRAIL is associated with remission of ulcerative colitis.Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.Esophageal pyogenic granuloma developed after short-term follow-up.Polypoid change in cytomegalovirus gastritis following treatment.Involvement of bone marrow-derived cells in healing of experimental colitis in rats.Managing hepatitis B virus carriers with systemic chemotherapy or biologic therapy in the outpatient clinic.
P50
Q26782855-5A757FAE-1775-47D0-A4EA-A57CC0F25E97Q26853636-1D128C96-DEDE-427C-95E5-1EA87FE937B2Q27006510-238BE80A-3910-4ED5-8C2B-929A9AA5EF5AQ33413675-B0ECC8C7-7586-40B3-8F9C-3F4E7A220052Q33628113-67325705-1DE9-44CE-B1EC-CE127C175FFAQ33829784-D632975F-67A6-4366-AEAB-242E1A739816Q34320528-D3DB105C-3333-4CA1-B322-3CE1D0248C2CQ35579521-8D286B1B-1D89-4E6B-A8C4-B8B2032B9949Q36439801-3506AEAA-A8F5-4123-B486-B741E12CEBABQ36798741-03CB44FC-19CE-4F29-8BD2-470F8BFA5997Q36885024-9924983E-E201-401C-9596-06BB38086EA3Q36969641-7AB3AAD6-6527-4194-A3FC-0BA3460BDE35Q37507967-481DCB72-D976-478F-A394-6FFDC134AB91Q37507982-2B36BC63-7E67-45CD-AEBE-10080F8F0E39Q37507987-9EF4A877-2238-4707-BAF6-538A69274CE1Q37708037-FF9DBED9-CBA4-46CC-8983-0E97026493C0Q38148677-75291D92-653A-4A84-88E0-883767DDA074Q38231620-1C9762F2-F35A-49FD-911C-212A11CAA4EEQ38633672-DE13543F-8980-4DE4-8D3A-C5C50CDD44DCQ38916013-DECB074F-2956-467A-9EBE-0E9661304606Q40407698-FC6002AA-90B6-47B5-A1DA-5CD467E49C75Q40437695-F851C8C4-347D-43E7-BF21-AD4E12656A29Q40978332-B038DA42-7B7D-4D2A-908D-E4937C151835Q41135911-1F4C02F3-18DD-4AFF-A9A8-00D75A8653AFQ41355060-B7DC9190-87BD-4293-82F3-E24DA3071B7CQ41380679-2973E15E-3CA1-441C-867A-EE02F34BBFC1Q41389333-956BF0D9-6021-45B0-BAB0-29CA9C5282C0Q42208904-2276AF21-D798-4F15-B221-2EC757A00227Q42252522-2001CEF1-9EA1-470D-9096-96BAB33E83AEQ42466155-918B605E-432A-4846-A55A-F7D22994FC89Q43120516-021EB351-8ED4-414D-B464-41A6530BAB1AQ43682803-74D10EEE-2670-4B9C-BADF-E7C1A623FA4CQ44254852-5CEFADED-5428-4E3D-94C4-F7F271393CD2Q44284612-769D2557-6A83-4BA7-8347-207EF14150C3Q44476443-6D8036AB-4A42-484A-818A-B7D98E3FA273Q44635454-5FA36EB0-593B-4B18-9530-6BEB17F15649Q44651969-25077284-2068-41B8-B0D4-BD2C14138B4BQ45104271-087F0A99-5E68-46D3-B761-CCF5B4060794Q45230117-912ED1CD-C506-48BB-B7C2-CE14D9E704E6Q45355599-8D42E2B6-270A-440F-AF97-2993E6FE5F4C
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tsutomu Nishida
@ast
Tsutomu Nishida
@en
Tsutomu Nishida
@es
Tsutomu Nishida
@nl
Tsutomu Nishida
@sl
type
label
Tsutomu Nishida
@ast
Tsutomu Nishida
@en
Tsutomu Nishida
@es
Tsutomu Nishida
@nl
Tsutomu Nishida
@sl
prefLabel
Tsutomu Nishida
@ast
Tsutomu Nishida
@en
Tsutomu Nishida
@es
Tsutomu Nishida
@nl
Tsutomu Nishida
@sl
P1053
M-5744-2017
P106
P1153
7402547750
P2038
Tsutomu_Nishida
P21
P31
P3829
P496
0000-0003-4037-9003